Finally....President Obama's actions on enforcement are showing results.
The patch, known as Menaflex and manufactured by ReGen Biologics, was so different from earlier devices that it should have been tested far more thoroughly before approval, officials determined.
“We are concluding that the science does not support a decision to clear the device, and therefore we’ll move forward to rescind” its approval, Dr. Jeffrey E. Shuren, director of the F.D.A.’s device center, said in an interview.
The F.D.A. has never admitted that it approved a drug or device mistakenly, never rescinded such an approval without citing new information about the product, never admitted that a regulatory decision was influenced by politics, and never accused a former commissioner of questionable conduct.
Gerald E. Bisbee Jr., chairman and chief executive of ReGen, said in a statement that the company was “weighing its options.”..."
No comments:
Post a Comment